Insider Trading & Ownership - Joshi Abhay

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Joshi Abhay

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-03-15
Tax Withholding
2022-03-17
5:56 pm
N/A
N/A
Revance Therapeutics Inc.RVNCJoshi Abhay
COO, President of R&D
2,607$15.79120,708
(Direct)
View
2022-02-15
Tax Withholding
2022-02-17
8:51 pm
N/A
N/A
Revance Therapeutics Inc.RVNCJoshi Abhay
COO, President, R&D
5,053$13.35123,315
(Direct)
View
2021-03-15
Tax Withholding
2021-03-17
7:27 pm
N/A
N/A
Revance Therapeutics Inc.RVNCJoshi Abhay
COO, President, R&D
1,354$27.73128,368
(Direct)
View
2021-02-15
Tax Withholding
2021-02-19
8:10 pm
N/A
N/A
Revance Therapeutics Inc.RVNCJoshi Abhay
COO, President, R&D
4,848$28.97129,722
(Direct)
View
2021-02-02
Option Award
2021-02-04
9:16 pm
N/A
2031-02-01
Revance Therapeutics Inc.RVNCJoshi Abhay
COO, President, R&D
63,545$0175,495
(Direct)
View
2020-09-30
Option Award
2020-10-02
8:31 pm
N/A
N/A
Revance Therapeutics Inc.RVNCJoshi Abhay
COO, President, R&D
17,500$0111,950
(Direct)
View
2020-09-30
Tax Withholding
2020-10-02
8:31 pm
N/A
N/A
Revance Therapeutics Inc.RVNCJoshi Abhay
COO, President, R&D
7,382$25.14111,950
(Direct)
View
2020-03-15
Tax Withholding
2020-03-17
8:34 pm
N/A
N/A
Revance Therapeutics Inc.RVNCJoshi Abhay
COO, President of R&D
1,354$15.5101,832
(Direct)
View
2020-02-15
Tax Withholding
2020-02-19
8:22 pm
N/A
N/A
Revance Therapeutics Inc.RVNCJoshi Abhay
COO, President, R&D
3,325$25.33103,186
(Direct)
View
2020-01-23
Option Award
2020-01-24
8:16 pm
N/A
2030-01-22
Revance Therapeutics Inc.RVNCJoshi Abhay
Chief Operating Officer
171,500$0253,011
(Direct)
View
2020-01-15
Tax Withholding
2020-01-17
8:12 pm
N/A
N/A
Revance Therapeutics Inc.RVNCJoshi Abhay
Chief Operating Officer
4,441$22.8981,511
(Direct)
View
2019-12-14
Tax Withholding
2019-12-17
7:56 pm
N/A
N/A
Revance Therapeutics Inc.RVNCJoshi Abhay
Chief Operating Officer
2,971$15.9985,952
(Direct)
View